BALDINI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 18.577
AS - Asia 9.621
EU - Europa 6.696
SA - Sud America 1.643
Continente sconosciuto - Info sul continente non disponibili 947
AF - Africa 569
OC - Oceania 60
Totale 38.113
Nazione #
US - Stati Uniti d'America 17.960
SG - Singapore 2.981
CN - Cina 2.740
IT - Italia 1.774
HK - Hong Kong 1.584
BR - Brasile 1.313
SE - Svezia 1.088
VN - Vietnam 1.018
DE - Germania 809
BG - Bulgaria 595
GB - Regno Unito 485
CA - Canada 433
FR - Francia 403
FI - Finlandia 365
RU - Federazione Russa 286
TR - Turchia 273
IN - India 236
NL - Olanda 202
JP - Giappone 190
CI - Costa d'Avorio 155
UA - Ucraina 136
NG - Nigeria 106
AT - Austria 103
ES - Italia 101
MX - Messico 95
BD - Bangladesh 89
AR - Argentina 87
SN - Senegal 87
KR - Corea 77
IQ - Iraq 67
PL - Polonia 59
AU - Australia 55
CH - Svizzera 55
BE - Belgio 52
MA - Marocco 51
EC - Ecuador 50
ID - Indonesia 49
ZA - Sudafrica 49
CO - Colombia 46
CL - Cile 40
UZ - Uzbekistan 36
VE - Venezuela 35
PK - Pakistan 32
IE - Irlanda 31
SA - Arabia Saudita 31
KE - Kenya 28
LT - Lituania 23
PY - Paraguay 23
EG - Egitto 22
PH - Filippine 22
MY - Malesia 21
PE - Perù 21
IL - Israele 19
RO - Romania 19
DZ - Algeria 18
TW - Taiwan 18
CR - Costa Rica 17
GR - Grecia 17
JO - Giordania 17
JM - Giamaica 16
UY - Uruguay 15
LB - Libano 14
PT - Portogallo 14
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
BO - Bolivia 10
DK - Danimarca 10
ET - Etiopia 10
NP - Nepal 10
AL - Albania 9
HN - Honduras 9
PS - Palestinian Territory 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
EU - Europa 8
IR - Iran 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
AM - Armenia 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NO - Norvegia 7
TH - Thailandia 7
AO - Angola 6
BJ - Benin 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HU - Ungheria 6
PA - Panama 6
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
OM - Oman 5
LU - Lussemburgo 4
MD - Moldavia 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 37.112
Città #
Ashburn 1.922
Singapore 1.647
Woodbridge 1.634
Hong Kong 1.547
Dallas 1.274
San Jose 1.154
Ann Arbor 1.127
Houston 1.051
Santa Clara 1.021
Fairfield 992
Chandler 897
Shanghai 655
Beijing 622
Sofia 591
New York 485
Seattle 444
Wilmington 381
Boardman 373
Milan 362
Cambridge 333
Los Angeles 298
Princeton 279
Ho Chi Minh City 275
Munich 271
Ottawa 269
Lawrence 234
Council Bluffs 222
Medford 218
Lauterbourg 189
Hanoi 184
Nanjing 167
Abidjan 155
Serra 154
Florence 150
Jacksonville 147
Tokyo 147
Des Moines 141
Hefei 130
London 126
Frankfurt am Main 122
Helsinki 122
São Paulo 121
Izmir 108
Istanbul 107
Lagos 105
Dearborn 102
Dong Ket 96
Redondo Beach 92
Rome 88
Dakar 87
Bremen 85
Buffalo 80
Vienna 77
Turku 74
San Diego 71
Pisa 67
Pune 59
Redwood City 57
Seoul 57
Ogden 55
Amsterdam 54
Chicago 51
Nanchang 50
Nuremberg 47
Orem 45
Fuzhou 44
Warsaw 43
Falls Church 42
Kunming 42
Düsseldorf 41
Lancaster 41
Shenyang 40
Guangzhou 38
Montreal 38
Rio de Janeiro 38
Bern 37
Atlanta 36
Belo Horizonte 36
Brussels 35
Paris 35
San Francisco 35
Hebei 34
Marseille 34
Phoenix 34
Tashkent 34
Boulder 33
Da Nang 32
Denver 31
Dublin 31
Jüchen 31
Changsha 30
Chennai 29
Brooklyn 28
Haiphong 28
Toronto 28
Manchester 27
Boston 26
Jiaxing 26
Livorno 25
Baghdad 24
Totale 25.533
Nome #
Sjögren syndrome 1.422
Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: Review of the literature and a cross-sectional prospective experience 321
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 238
Skin manifestations and sjögren’s syndrome 236
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 231
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 230
Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study 222
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 213
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 206
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 205
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 204
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 203
Classification criteria 197
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 196
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 194
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 191
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 190
Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature 189
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 187
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 187
Proteomics approach as a tool for salivary fingerprint characterization able to discriminate different Sjögren’s syndrome phenotype. 185
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 185
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 184
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 184
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 180
Skin manifestations and cryoglobulinemia 180
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 179
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 176
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 175
Anti-Sm and anti-RNP antibodies 175
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 173
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 172
Biomarkers for Sjögren's syndrome 172
Ultra-High Frequency Ultrasound, A Promising Diagnostic Technique: Review of the Literature and Single-Center Experience 172
Undifferentiated connective tissue diseases (UCTD) 171
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 171
Classification criteria for Sjogren's syndrome: A critical review. 164
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 164
The association of Sjögren syndrome and autoimmune thyroid disorders 163
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 162
Primary Sjogren's Syndrome: clinical and serological feature of a single centre [Sindrome di Sjogren primitiva: Descrizione clinica e sierologica di una casistica monocentrica] 162
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 160
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients 160
Myeloid neoplasms and autoimmune diseases: markers of association 159
Classification criteria in Sjögren’s syndrome 158
Mucocutaneous manifestations of Sjögren's Syndrome 157
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 157
Clinical manifestations and treatment of Churg-Strauss syndrome 156
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. 156
Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab 154
Salivary histidine-rich glycoprotein: a novel putative biomarker for autoimmune disease. 154
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 154
Classification criteria for Sjogren's syndrome: A critical review. 153
Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? 153
Treatment of chronic hepatitis C infection with cryoglobulinemia. 152
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 152
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 152
COVID-19: the new challenge for rheumatologists 152
Proteomic analysis of the saliva: A clue for understanding primary from secondary Sjogren's syndrome? 151
Ultra-High Frequency Ultrasound (Uhfus) Applications in Sjogren Syndrome: Narrative Review and Current Concepts 148
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 147
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome A consensus and data-driven methodology involving three international patient cohorts 147
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 147
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 146
Sjögren's syndrome: state of the art on clinical practice guidelines 146
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 145
Salivary Cystatin C and the imbalance between cysteine proteases and their inhibitors in Churg Strauss Syndrome. 145
Patterns of inflammation and dysfunction in pSS: identification of proteomic salivary biomarkers correlated with different disease phenotypes. 144
Aderenza allo screening per il cancro della cervice uterina in una coorte italiana di donne affette da LES [Adherence to cervical cancer screening in an Italian SLE cohort] 144
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study 143
Artrite reumatoide e analisi proteomica della saliva 143
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. 143
Proteomic diagnosis of Sjögren's syndrome 143
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 143
The economic impact of gout: a systematic literature review. 142
Analysis of the evolution of UCTD to defined CTD after a long-term follow-up. 142
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? 142
Cryoglobulinemic vasculitis: a 2023 update 142
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. 141
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 141
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 141
Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome 140
The CoV-2 outbreak: how hematologists could help to fight Covid-19 140
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 140
Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome 139
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 139
One year in review 2019: Sjögren’s syndrome 139
Primary-Sjögren's-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies. 138
A Clinical prediction rule for lymphoma development in primary and secondary Sjogren’s syndrome. 138
COVID-19: the new challenge for rheumatologists. First update 138
Evoluzione verso connettiviti definite in una popolazione di pazienti affetti da “early undifferentiated connective tissue disease” [Analysis of the evolution to defined connective tissue diseases of patients with early undifferentiated connective tissue diseases (UCTD)] 137
Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren's Syndrome and Overlapping Disorders. 136
Chronic skin lichenification as unusual presentation of eosinophilic granulomatosis with polyangitis: case report and literature review 136
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 136
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis 135
One year in review 2018: Sjögren's syndrome 135
Emerging trends in Sjögren's syndrome: basic and translational research. 134
Updates on Sjögren's syndrome: from proteomics to protein biomarkers 134
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis 133
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 133
Totale 17.666
Categoria #
all - tutte 114.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.600 0 181 39 170 481 380 98 137 137 99 161 717
2022/20233.435 440 430 248 288 408 380 43 237 580 50 265 66
2023/20242.607 240 241 280 178 387 507 140 72 54 74 131 303
2024/20258.298 74 322 120 405 701 1.001 801 470 808 1.056 962 1.578
2025/202610.499 693 1.279 1.423 886 1.141 874 1.541 523 586 909 405 239
2026/2027541 393 148 0 0 0 0 0 0 0 0 0 0
Totale 38.113